2014考研英語:閱讀經(jīng)典試題及詳解(四十七)_跨考網(wǎng)
2014考研英語:閱讀經(jīng)典試題及詳解(四十七)
WHAT do you do when everyone hates you? That is the problem faced by America's pharmaceutical industry. Despite its successes in treating disease and extending longevity, soaring health-care costs and bumper profits mean that big drug firms are widely viewed as exploitative, and regarded almost as unfavourably as tobacco and oil firms (see chart). Last week, at a conference organised by The Economist in Philadelphia, the drug industry was offered some advice from an unlikely source: a tobacco firm. Steven Parrish of Altria, the conglomerate that includes Philip Morris, gave his perspective on how an industry can improve its tarnished public image.
Comparing the tobacco and pharmaceutical industries might seem absurd, or even offensive. "Their products kill people. Our products save people's lives," says Alan Holmer, the head of the Pharmaceutical Research and Manufacturers of America, an industry association. Yet the drug giants currently face an unprecedented onslaught of class-action lawsuits and public scrutiny; industry bosses are being grilled by lawmakers asking who knew what and when. It is all reminiscent of what happened to the tobacco industry in 1994.
Mr Parrish advised drug firms to abandon their bunker mentality and engage with their critics. Rather than arguing about the past, he said, it is better to move on, and give people something new to think about. (Philip Morris now acknowledges, for example, that cigarettes are addictive and deadly, and is trying to develop less harmful products.) Not everyone is open to persuasion, so focus on those who are, he said. But changing opinions takes time and demands deeds as well as words: "This is not about spin, this is about change."
The pharmaceutical industry is pursuing a range of initiatives to mollify its critics, Mr Holmer noted in his own speech. But Mr Parrish suggested that speaking with one voice through a trade association might be counter-productive, since it can give the impression that the industry is a monolithic cartel. And too much advertising, he said, can actually antagonise people further.
The audience was generally receptive, claims Mr Parrish. This is not the first time he has offered his thoughts on dealing with implacable critics. At a conference at the University of Michigan last year, he offered America's State Department advice on improving America's image in the Middle East. So does his prescription work? There has been a positive shift in attitudes towards tobacco firms, if only a small one. But at least, for once, a tobacco firm is peddling a cure, rather than a disease.
2022考研初復(fù)試已經(jīng)接近尾聲,考研學(xué)子全面進(jìn)入2023屆備考,跨考為23考研的考生準(zhǔn)備了10大課包全程準(zhǔn)備、全年復(fù)習(xí)備考計劃、目標(biāo)院校專業(yè)輔導(dǎo)、全真復(fù)試模擬練習(xí)和全程針對性指導(dǎo);2023考研的小伙伴針也已經(jīng)開始擇校和復(fù)習(xí)了,跨考考研暢學(xué)5.0版本全新升級,無論你在校在家都可以更自如的完成你的考研復(fù)習(xí),暑假集訓(xùn)營帶來了院校專業(yè)初步選擇,明確方向;考研備考全年規(guī)劃,核心知識點(diǎn)入門;個性化制定備考方案,助你贏在起跑線,早出發(fā)一點(diǎn)離成功就更近一點(diǎn)!
考研院校專業(yè)選擇和考研復(fù)習(xí)計劃 | |||
2023備考學(xué)習(xí) | 2023線上線下隨時學(xué)習(xí) | 34所自劃線院??佳袕?fù)試分?jǐn)?shù)線匯總 | |
2022考研復(fù)試最全信息整理 | 全國各招生院校考研復(fù)試分?jǐn)?shù)線匯總 | ||
2023全日制封閉訓(xùn)練 | 全國各招生院??佳姓{(diào)劑信息匯總 | ||
2023考研先知 | 考研考試科目有哪些? | 如何正確看待考研分?jǐn)?shù)線? | |
不同院校相同專業(yè)如何選擇更適合自己的 | 從就業(yè)說考研如何擇專業(yè)? | ||
手把手教你如何選專業(yè)? | 高校研究生教育各學(xué)科門類排行榜 |
相關(guān)推薦
跨考考研課程
班型 | 定向班型 | 開班時間 | 高定班 | 標(biāo)準(zhǔn)班 | 課程介紹 | 咨詢 |
秋季集訓(xùn) | 沖刺班 | 9.10-12.20 | 168000 | 24800起 | 小班面授+專業(yè)課1對1+專業(yè)課定向輔導(dǎo)+協(xié)議加強(qiáng)課程(高定班)+專屬規(guī)劃答疑(高定班)+精細(xì)化答疑+復(fù)試資源(高定班)+復(fù)試課包(高定班)+復(fù)試指導(dǎo)(高定班)+復(fù)試班主任1v1服務(wù)(高定班)+復(fù)試面授密訓(xùn)(高定班)+復(fù)試1v1(高定班) | |
2023集訓(xùn)暢學(xué) | 非定向(政英班/數(shù)政英班) | 每月20日 | 22800起(協(xié)議班) | 13800起 | 先行階在線課程+基礎(chǔ)階在線課程+強(qiáng)化階在線課程+真題階在線課程+沖刺階在線課程+專業(yè)課針對性一對一課程+班主任全程督學(xué)服務(wù)+全程規(guī)劃體系+全程測試體系+全程精細(xì)化答疑+擇校擇專業(yè)能力定位體系+全年關(guān)鍵環(huán)節(jié)指導(dǎo)體系+初試加強(qiáng)課+初試專屬服務(wù)+復(fù)試全科標(biāo)準(zhǔn)班服務(wù) |